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Toxicity of Styrene Vapor in Hepatocyte
Monolayers at Low Oxygen Tensions
Anita K. Costa* and James R. Trudell*
Hepatocyte monolayer cultures were exposed to 6000 ppm styrene vapor at 20%, 2%, or 1% 02 and
assayed for signs of cell damage immediately following the 2-hr exposure and then 24 hr later.
Oxygen concentrations were used that were previously shown to maximize lipid peroxidation and
to predispose hepatocyte monolayers to chemical injury. The use of two time points allowed
assessment of acute injury as well as injury that requires several hours to manifest itself. The
uptake of styrene into the buffer in the culture dishes was measured by gas chromatography and
was found to be 0.49, 0.68, and 0.74 mM at 15, 60, and 120 min, respectively. However, as measured
by release of aspartate aminotransferase and inclusion of trypan blue, no toxicity was evident at
either time point, irrespective of the oxygen concentration. This study shows that despite the
weakening of hepatocyte defense mechanisms by hypoxia, styrene is not acutely toxic to these
cells. Furthermore, if any damage to DNA, RNA, or the capability for protein synthesis occurs
during exposure to styrene, it is insufficient to cause lysis within 24 hr.
Introduction
Over 3 million tons of liquid styrene monomer are
used annually in the manufacture ofpolystyrene plas-
tics; styrene therefore poses a potential occupational
hazard for many workers. The maximum allowable
concentration (MAC) for styrene in the United States
is 100 ppm with the threshold limit value (TLV) and
time weighted average (TWA) set at 50 pm (1). It has
been established that the biotransformation of sty-
rene monomer is a prerequisite for hepatic injury [for
reviews on the metabolism, see (2,3)]. The reactive
metabolite responsible is proposed to be the epoxide
of styrene, styrene oxide, resulting from the oxidation
of styrene by the hepatic mixed-function oxidases.
However, conflicting reports cast doubt on whether
the toxic or mutagenic species is the epoxide (4-7),
and other reactive intermediates have been proposed
and are being actively sought (7). Over the years there
have been many studies with varying results concern-
ing the toxicity, mutagenicity, or carcinogenicity of
this compound, but the general theme emerging from
these reports is that damage is only observed after
multiple exposures (1,8). There has been one report of
acute liver injury in young rats following a single
high IP dose of styrene (878 mg/kg) (9). In this study,
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using 35% of the LD50 of styrene, the addition of
inducers and inhibitors of the mixed-function oxi-
dases had no effect on the extent of injury, in contrast
to other studies using lower styrene concentrations
where inhibitors and inducers played a significant
role (7,10). The in vivo damage observed in the former
study would be consistent with styrene causing direct
solvent injury (11) or alterations in hepatic blood flow
(12). Halothane, which is a CNS depressant, causes
alterations in blood flow to the liver and results in
oxygen concentrations in the centrilobular area of the
liver lobule dropping from 20 to 40 FM, under condi-
tions of normal blood flow to below ,uM (12,13). There-
fore, it is possible that styrene, which is also a CNS
depressant above 50 ppm (1), could also cause similar
alterations.
This paper addresses the role that oxygen may play
in acute hepatocellular injury by styrene in monolay-
ers of primary hepatocytes: Do low prevailing oxygen
concentrations influence styrene toxicity? Styrene
metabolism is known to deplete liver glutathione
(GSH) and, in turn, cause lipid peroxidation (14), a
scenario that theoretically should result in potentia-
tion of the toxicity of the compound as the oxygen
concentration drops because lipid peroxidation pro-
ceeds maximally at 0.2% 02 (15,16). We investigated
the toxicity of 6000 ppm styrene in hepatocyte mono-
layer cultures at 20%, 2%, and 1% 02 and assayed for
signs of cell damage immediately following a 2-hr
exposure and 24 hr later.COSTA AND TRUDDELL
Methods
Hepatocyte Isolation
Hepatocytes were prepared from male Fischer 344
rats (180 to 240 g) by in situ perfusion of the liver
with collagenase (17,18). The isolated and washed
hepatocytes were suspended in 100 mL of a medium
(complete M-199) containing GIBCO M-199 with
Earle's salts, pH 7.3, 100 U penicillin/mL, 100 jg
streptomycin/mL, 4.5 jg gentamicin/mL, 1 jg trans-
ferrin/mL, 0.25 mM ascorbic acid, 4.12 jM folic acid,
1.24 mM pyruvate, 8 U insulin/mL, 100 jiM 5-ami-
nolevulinic acid, 0.25% bovine serum albumin, and
10% heat-inactivated fetal calf serum (GIBCO). The
5-aminolevulinic acid has been shown to maintain
total cytochrome P-450 content at in vivo levels (19).
Aliquots of 1 mL containing approximately 3 x 106
cells were added to collagen-coated 60 mm Lux
Permanox Contur (Flow Laboratories) culture dishes,
and allowed to attach for 120 min at 37°C in 5% C02/
95% air. These culture dishes were preincubated at
37°C for 3 hr in complete M-199 with 20% fetal calf
serum and 1 jM dexamethasone to form a matrix,
which facilitates attachment, prior to addition of cell
suspension aliquots. The high oxygen permeability of
the Permanox dishes permits rapid equilibration of
the cells and medium with any desired gaseous
environment.
The hepatocyte monolayers were then washed twice
after the 120-min attachment period and covered with
2 mL complete M-199. Cells at this point were more
than 95% viable as assayed 5 to 15 min after addition
of trypan blue, by observing five fields of approxi-
mately 200 cells at 200 x magnification with a Nikon
Diaphot inverted microscope. Cytochrome P-450 con-
tent at isolation and 24 hr after plating were ascer-
tained, as described previously (18), and corresponded
closely to in vivo levels. Previous studies in this labo-
ratory involving identically prepared hepatocytes
demonstrated that the metabolic activity of these
cells was unchanged after 3.5 hr of 2% 02 hypoxia
(20).
Experimental Protocol
The styrene exposure experiments were initiated 18
hr following the isolation and plating of the hepato-
cytes. Prior to each styrene or control exposure, the
monolayers were washed twice with buffer and cov-
ered with 2 mL complete M-199 medium and then
checked for confluency with an inverted microscope.
Cells were then removed from a standard incubator
(5% C02/95% air at 37°C) and placed in a Billups-
Rothenberg (Del Mar, CA) modular incubator cham-
ber for exposure to styrene and/or selected hypoxic
gas mixtures. The incubator chamber was altered to
permit the gas mixture to flow in from the top of the
chamber onto the surface of a 100-mm Petri dish
filled with sterile H20 that was placed on the top
shelf. The resulting turbulence caused a uniform gas
flow over five culture dishes placed on each of the two
lower shelves. The outflow port at the incubator
chamber was extended upward to the surface with
tubing, and the entire sealed incubator chamber was
immersed in a 37°C water bath.
The cells were exposed to stable concentrations of
styrene over the 2-hr exposure period at the various
oxygen tensions. The uptake and distribution of sty-
rene vapor into fluids and tissue compartments has
been thoroughly studied (21,22).
In order to measure the actual concentration of sty-
rene to which the hepatocytes were exposed, the Bil-
lups-Rothenberg modular incubator was modified as
follows: Four holes were drilled in the top such that
each hole allowed withdrawal of samples from two
culture dishes. The holes were plugged with vacuum
wax except during sampling. After 15, 30, 45, 60, and
120 min of exposure of Lux Permanox culture dishes
containing Earle's buffer to saturate styrene vapor
from a copper kettle vaporizer (Foregger, Roslyn
Heights, NY), 0.5-mL samples (in duplicate) were
withdrawn and added to 0.5 mL carbon disulfide in a
1-mL reacti-vial that was then sealed with foil. The
sample was mixed vigorously on a vortex mixer for 1
min, the phases were allowed to separate, and two 1-
jL aliquots were analyzed by gas chromatography
(n = 4 for each time point).
Extraction of styrene into carbon disulfide and
analysis by gas chromatography has been previously
described (1). Gas chromatography was performed on
a Varian 2100 on a 30 x 0.53 mm (i.d.) DX-624 column
(J & W Scientific, Folsom, CA) with a helium flow of 8
mL/min. The column, injector, and detector tempera-
tures were 90, 130, and 130°C, respectively. Styrene
was dissolved in carbon disulfide to prepare a 1-mM
reference sample. Styrene vapor directly from the
copper kettle vaporizer was bubbled for 30 min into 10
mL of Earle's buffer, pH 7.4, maintained at 37°C in
order to determine the highest styrene concentration
that could be achieved in a culture dish at full equilib-
rium. Earle's buffer, rather than complete M-199, was
used in these control experiments in order to prevent
the formation of an emulsion during extraction that
is caused by serum proteins.
The gas mixtures of either 1, 2, or 20% 02/5% C02/
balance N2 were made with mass flow controllers
(Porter Instrument Co., Inc., Hatfield, PA) at 1 L/
min. An oxygen monitor (OHMEDA 5100, B.O.C.
Health Care, Madison, WI), calibrated against room
air and various O2/N2 mixtures, was used to confirm
the desired 02 concentrations. The concentration of
styrene (6000 ppm) was the result of the entire flow
going through the copper kettle vaporizer at 20°C (1).
The gas mixture or gas/styrene mixture was passed
through a glass frit humidifier that humidified and
warmed it to 37°C before entry into the exposure
chamber. All groups ofdishes remained in the incuba-
tor chamber for a 2-hr exposure with lids off. Experi-
ments in the different groups were performed
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sequentially throughout the day, with the controls
done before the chamber was exposed to styrene.
Immediately following each experimental exposure,
supernatants were removed from 5 of the 10 identical
monolayers in each group. The supernatants were
centrifuged to separate dead cells and debris, and the
resulting supernatants were analyzed for aspartate
aminotransferase (AST) release using Sigma Kit No.
505 (Sigma Chemical Co., St. Louis, MO). A supple-
mentary assessment of cell death was obtained by
measuring trypan blue exclusion of the cells following
removal of the supernatant. The remaining five
dishes were incubated in 5% C02/95% air at 37°C for
24 hr. At the end of this 24-hr period, the superna-
tants from these dishes were tested for AST release
and trypan blue exclusion as described above.
Data Analysis
Experiments were performed on two separate
hepatocyte preparations (total n = 10 for each point)
to average dish-to-dish and rat-to-rat variations. The
AST release for each dish was determined as
described in the Sigma Kit No. 505; it was compared
to complete AST release caused by lysis with 0.2%
Triton X-100 and expressed as a percent. It should be
noted that 80% cell lysis, as measured by AST
release, corresponded to 100% cell death as monitored
by their inability to exclude trypan blue. Multiple
regression was performed with Statworks software
(Cricket Software Inc., Malvern, PA) on an Apple
MacIntosh II computer.
Results
A preliminary study in this laboratory using 1000
ppm (10-fold MAC) for 2 hr at 1%, 2%, and 20% 02
resulted in no significant cell damage above that
found with control monolayers as monitored by the
release of AST and by the ability of the monolayers to
exclude trypan blue (data not shown). To maximize
the possibility of measuring styrene toxicity, a study
was performed with saturated styrene vapor (6000
ppm) at oxygen concentrations of 1%, 2%, and 20%
for 2 hr. The styrene concentration was measured by
gas chromatography in the buffer contained in Lux
Permanox dishes during actual incubation conditions
at 15, 30, 45, 60, and 120 min. The uptake of styrene is
shown in Figure 1. It is seen that at 15 min the con-
centration is 65% of the final value of 0.74 ± 0.02 mM
at 120 min. Bubbling the styrene vapor from the cop-
per kettle vaporizer at 20°C directly into Earle's
buffer maintained at 37°C for 30 min produced a final
styrene concentration of 0.73 ± 0.02 mM. Saturating
Earle's buffer with liquid styrene at 37°C produced a
concentration of 3.5 mM that agrees well with the 2.5
mM in water saturated at 20°C as previously
described (1). The concentrations measured in culture
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FIGURE 1. Relationship between styrene concentration (± SE) in
Earle's buffer contained in Lux Permanox culture dishes main-
tained at 37°C versus time of exposure to styrene vapor from a
copper kettle vaporizer (6000 ppm). At each time point aliquots
were removed from duplicate culture dishes and the extracts
were analyzed by gas chromatography in duplicate (-_, n = 4).
The styrene vapor from the copper kettle was bubbled directly
into Earle's buffer at 37°C for 30 min (-_-, n = 5) as a reference
for full equilibrium.
dishes at 60 and 120 min were not statistically differ-
ent (p < 0.05) from each other, or from buffer satu-
rated directly for 30 min, by students unpaired t-test.
No hepatocellular damage was observed immedi-
ately following the exposure at any of the oxygen
concentrations (Fig. 2). Since the adverse effects of
phenomena such as depletion of GSH, accumulation
80 -
0
40 -
20
0
1021
C +5
1 %
C +5 C +S
20 %
FIGURE 2. Relationship between percent cell death (± SE) and oxy-
gen concentration as measured by AST release immediately
after (U) and 24 hr after (U) a 2-hr exposure to 6000 ppm of
styrene vapor. Multiple regression showed that there was no
statistically significant effect on cell death by oxygen, styrene,
or time.
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of lipid peroxides, or the inhibition of protein synthe-
sis may take time to develop, as has been found with
halothane (18) and 1, 2-dibromoethane exposure (23),
half of the monolayers from each group were incu-
bated for another 24 hr at 20% 02 Cell damage was
ascertained as above and no increase in cell death was
observed at the 24-hr time point.
Multiple regression was performed on the data.
Styrene and oxygen had no significant effect on cell
death, while time exhibited a weak correlation with
increasing cell death at 24 hr. However, the adjusted
coefficient of determination (R2) was only 0.145, indi-
cating that none ofthe three variables posed a signifi-
cant factor in cell death.
Discussion
The subject of styrene toxicity was thoroughly
reviewed in 1983 by the National Institute for Occupa-
tional Safety and Health (NIOSH) in a document
titled "Criteria for Recommended Standard, Occupa-
tional Exposure to Styrene" (1). Although this review
presented clear evidence for toxicity to several other
organ systems, it concluded that research to clarify
the role of styrene on liver status is needed. Previous
studies in animals (7-10) have shown that it is very
unlikely that hepatotoxicity would result from acute
exposure to styrene at the threshold limit value of 50
ppm set by NIOSH (1). Therefore, it was appropriate
to investigate possible hepatotoxicity resulting from
the very much higher styrene concentrations that
could occur during industrial accidents or spills of
liquid styrene. However, exposure of animals to high
concentrations of styrene is complicated by a variety
of CNS effects (1); among these is abnormal pulmo-
nary function. Because hypoxia alone has been shown
to cause hepatotoxicity (12,13), it may be impossible
to separate the effect of styrene metabolism alone in
an in vivo model. In the present study, exposure to
high concentrations of styrene was investigated in an
in vitro system where both oxygen and styrene con-
centrations could be defined.
The hepatic metabolism of styrene proceeds with
the formation of the reactive common epoxide inter-
mediate, styrene oxide (2,3,10), the half-life of which
depends on the amount of epoxide hydrolase present
(7). Styrene metabolism is known to result in the
depletion of GSH and, in turn, cause lipid peroxida-
tion (14). In analogy to other xenobiotics that cause
depletion of GSH and lipid peroxidation, styrene the-
oretically should be hepatotoxic. Indeed, in vivo
experiments have shown that it can be under certain
conditions (7-9).
Our laboratory has had a particular interest in the
interrelationship between cellular hypoxia and
metabolism of xenobiotics (18,19,23). Oxygen tensions
in the pericentral region of the liver can range from
4% under normoxia to 1% or lower under severe hyp-
oxia (13). Hypoxia has been shown to lessen the abil-
ity of hepatocytes to withstand damage from the
calcium ionophore A23187 (24) or t-butyl hydroperox-
ide (25,26) while at the same time increasing lipid
peroxidation (16). In addition, we have used the sta-
bility of monolayers of hepatocytes in culture (17) to
show that some components of metabolic damage to
hepatocytes require several hours to be observable
(18,27).
The present study was designed to measure possible
toxicity to hepatocytes at a high concentration of sty-
rene and also at low but physiologically reasonable
oxygen concentrations where we (18,24,25,27) and
others (16,26) have observed increased hepatotoxicity.
Because it is possible that metabolites of styrene
cause damage to DNA, RNA, or other components of
protein synthesis that may result in a delayed onset
of toxicity, the viability of the hepatocytes was also
measured 24 hrs after exposure. However, a saturated
vapor of styrene at concentrations 60-fold higher than
the occupational MAC and at oxygen concentrations
ranging from 1 to 20% for 2 hr was not toxic immedi-
ately or after an additional 24 hr of normoxic
incubation.
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